Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00400
|
|||||
| Drug Name |
Daptomycin
|
|||||
| Synonyms |
Cidecin; Cubicin; Cubicin (TN); Dapcin; Daptomicina; Daptomicina [Spanish]; Daptomycin (JAN/USAN/INN); Daptomycin [USAN:INN:BAN]; Daptomycine; Daptomycine [French]; Daptomycinum; Daptomycinum [Latin]; Deptomycin; LY-146032; LY146032; MK-3009; N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon1-lactone; N-decanoyl-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine 1.13-3.4-lactone; N-decanoyl-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon(1)-lactone; N-decanoyl-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-ox
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C72H101N17O26
|
|||||
| Canonical SMILES |
CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C
|
|||||
| InChI |
InChI=1S/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)
|
|||||
| InChIKey |
DOAKLVKFURWEDJ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 103060-53-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 1620.7 | Topological Polar Surface Area | 702 | ||
| Heavy Atom Count | 115 | Rotatable Bond Count | 35 | |||
| Hydrogen Bond Donor Count | 22 | Hydrogen Bond Acceptor Count | 28 | |||
| XLogP |
-5.1
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.